Sandra M Swain (Sandra Swain, S M Swain)

Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 56

Top Topics

Positive Breast Cancer

Tyrosine Kinase

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Nature communications

Clinical cancer research : an official journal of the American Association for Cancer Research

NPJ breast cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Charles E Geyer, Joanne L Blum, Greg Yothers, Lina Asmar, Patrick J Flynn, Nicholas J Robert, Judith O Hopkins, Joyce A O'Shaughnessy, Priya Rastogi, Shannon L Puhalla, Christie J Hilton, Chau T Dang, Henry Leonidas Gómez, Svetislava J Vukelja, Alan P Lyss, Devchand Paul, Adam M Brufsky, Linda H Colangelo, Sandra M Swain, Eleftherios P P Mamounas, Norman Wolmark
Long-Term Follow-Up of the Anthracyclines in Early Breast Cancer Trials (USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 [NRG Oncology]). Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Filipa C Lynce, Candace Mainor, Renee N Donahue, Xue Geng, Greg Jones, Ilana Schlam, Hongkun Wang, Nicole J Toney, Caroline Jochems, Jeffrey Schlom, Jay Zeck, Christopher M Gallagher, Rita Nanda, Deena Graham, Erica M Stringer-Reasor, Neelima Denduluri, Julie M Collins, Ami Chitalia, Shruti Tiwari, Raquel A Nunes, Rebecca Kaltman, Katia Khoury, Margaret Gatti-Mays, Paolo Tarantino, Sara M Tolaney, Sandra M Swain, Paula Pohlmann, Heather A Parsons, Claudine Isaacs
Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study. Nature communications 15 (1) (2024)
Filipa C Lynce, Candace Mainor, Renee N Donahue, Xue Geng, Greg Jones, Ilana Schlam, Hongkun Wang, Nicole J Toney, Caroline Jochems, Jeffrey Schlom, Jay Zeck, Christopher M Gallagher, Rita Nanda, Deena Graham, Erica M Stringer-Reasor, Neelima Denduluri, Julie M Collins, Ami Chitalia, Shruti Tiwari, Raquel A Nunes, Rebecca Kaltman, Katia Khoury, Margaret Gatti-Mays, Paolo Tarantino, Sara M Tolaney, Sandra M Swain, Paula Pohlmann, Heather A Parsons, Claudine Isaacs
Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study. Nature communications 15 (1) (2024)
Charles E Geyer, Joanne L Blum, Greg Yothers, Lina Asmar, Patrick J Flynn, Nicholas J Robert, Judith O Hopkins, Joyce A O'Shaughnessy, Priya Rastogi, Shannon L Puhalla, Christie J Hilton, Chau T Dang, Henry Leonidas Gómez, Svetislava J Vukelja, Alan P Lyss, Devchand Paul, Adam M Brufsky, Linda H Colangelo, Sandra M Swain, Eleftherios P P Mamounas, Norman Wolmark
Long-Term Follow-Up of the Anthracyclines in Early Breast Cancer Trials (USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 [NRG Oncology]). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (12) (2024)
Sandra M Swain, Ilana Schlam, D Max Smith, Cody Peer, Tristan Sissung, Keith Schmidt, Ming Tan, Ami Chitalia, Nanette Bishopric, Seth Steinberg, Hyoyoung Choo-Wosoba, Giulia Napoli, Christopher M Gallagher, Nadia Ashai, Kristen Whitaker, Candace Mainor, Shruti Tiwari, Nicole Swanson, Stacy Malloy, Claudine Isaacs, William Figg
Pharmacokinetics and Pharmacogenomics of Ribociclib in Black Patients with Metastatic Breast Cancer: The LEANORA study. Research square (2024)
Sandra M Swain, Ilana Schlam, D Max Smith, Cody Peer, Tristan Sissung, Keith Schmidt, Ming Tan, Ami Chitalia, Nanette Bishopric, Seth Steinberg, Hyoyoung Choo-Wosoba, Giulia Napoli, Christopher M Gallagher, Nadia Ashai, Kristen Whitaker, Candace Mainor, Shruti Tiwari, Nicole Swanson, Stacy Malloy, Claudine Isaacs, William Figg
Pharmacokinetics and Pharmacogenomics of Ribociclib in Black Patients with Metastatic Breast Cancer: The LEANORA study. Research square (2024)
Filipa C Lynce, Candace Mainor, Renee N Donahue, Xue Geng, Greg Jones, Ilana Schlam, Hongkun Wang, Nicole J Toney, Caroline Jochems, Jeffrey Schlom, Jay Zeck, Christopher M Gallagher, Rita Nanda, Deena Graham, Erica M Stringer-Reasor, Neelima Denduluri, Julie M Collins, Ami Chitalia, Shruti Tiwari, Raquel A Nunes, Rebecca Kaltman, Katia Khoury, Margaret Gatti-Mays, Paolo Tarantino, Sara M Tolaney, Sandra M Swain, Paula Pohlmann, Heather A Parsons, Claudine Isaacs
Author Correction: Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study. Nature communications 15 (1) (2024)
Filipa C Lynce, Candace Mainor, Renee N Donahue, Xue Geng, Greg Jones, Ilana Schlam, Hongkun Wang, Nicole J Toney, Caroline Jochems, Jeffrey Schlom, Jay Zeck, Christopher M Gallagher, Rita Nanda, Deena Graham, Erica M Stringer-Reasor, Neelima Denduluri, Julie M Collins, Ami Chitalia, Shruti Tiwari, Raquel A Nunes, Rebecca Kaltman, Katia Khoury, Margaret Gatti-Mays, Paolo Tarantino, Sara M Tolaney, Sandra M Swain, Paula Pohlmann, Heather A Parsons, Claudine Isaacs
Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study. Nature communications 15 (1) (2024)
Priya Rastogi, Hanna Bandos, Peter C Lucas, Laura van 't Veer, Jia-Perng J Wei, Charles E Geyer, Louis Fehrenbacher, Stephen K L Chia, Adam M Brufsky, Janice M Walshe, Gamini S Soori, Shaker R Dakhil, Soonmyung Paik, Sandra M Swain, Andrea R Menicucci, M William Audeh, Norman Wolmark, Eleftherios P P Mamounas
Utility of the 70-Gene MammaPrint Assay for Prediction of Benefit From Extended Letrozole Therapy in the NRG Oncology/NSABP B-42 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Charles E Geyer, Joanne L Blum, Greg Yothers, Lina Asmar, Patrick J Flynn, Nicholas J Robert, Judith O Hopkins, Joyce A O'Shaughnessy, Priya Rastogi, Shannon L Puhalla, Christie J Hilton, Chau T Dang, Henry Leonidas Gómez, Svetislava J Vukelja, Alan P Lyss, Devchand Paul, Adam M Brufsky, Linda H Colangelo, Sandra M Swain, Eleftherios P P Mamounas, Norman Wolmark
Long-Term Follow-Up of the Anthracyclines in Early Breast Cancer Trials (USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 [NRG Oncology]). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (12) (2024)
Charles E Geyer, Joanne L Blum, Greg Yothers, Lina Asmar, Patrick J Flynn, Nicholas J Robert, Judith O Hopkins, Joyce A O'Shaughnessy, Priya Rastogi, Shannon L Puhalla, Christie J Hilton, Chau T Dang, Henry Leonidas Gómez, Svetislava J Vukelja, Alan P Lyss, Devchand Paul, Adam M Brufsky, Linda H Colangelo, Sandra M Swain, Eleftherios P P Mamounas, Norman Wolmark
Long-Term Follow-Up of the Anthracyclines in Early Breast Cancer Trials (USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 [NRG Oncology]). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (12) (2024)
Filipa C Lynce, Candace Mainor, Renee N Donahue, Xue Geng, Greg Jones, Ilana Schlam, Hongkun Wang, Nicole J Toney, Caroline Jochems, Jeffrey Schlom, Jay Zeck, Christopher M Gallagher, Rita Nanda, Deena Graham, Erica M Stringer-Reasor, Neelima Denduluri, Julie M Collins, Ami Chitalia, Shruti Tiwari, Raquel A Nunes, Rebecca Kaltman, Katia Khoury, Margaret Gatti-Mays, Paolo Tarantino, Sara M Tolaney, Sandra M Swain, Paula Pohlmann, Heather A Parsons, Claudine Isaacs
Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study. Nature communications 15 (1) (2024)
Filipa C Lynce, Candace Mainor, Renee N Donahue, Xue Geng, Greg Jones, Ilana Schlam, Hongkun Wang, Nicole J Toney, Caroline Jochems, Jeffrey Schlom, Jay Zeck, Christopher M Gallagher, Rita Nanda, Deena Graham, Erica M Stringer-Reasor, Neelima Denduluri, Julie M Collins, Ami Chitalia, Shruti Tiwari, Raquel A Nunes, Rebecca Kaltman, Katia Khoury, Margaret Gatti-Mays, Paolo Tarantino, Sara M Tolaney, Sandra M Swain, Paula Pohlmann, Heather A Parsons, Claudine Isaacs
Author Correction: Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study. Nature communications 15 (1) (2024)
Eleftherios P P Mamounas, Hanna Bandos, Priya Rastogi, Yi Zhang, Kai Treuner, Peter C Lucas, Charles E Geyer, Louis Fehrenbacher, Stephen K L Chia, Adam M Brufsky, Janice M Walshe, Gamini S Soori, Shaker R Dakhil, Soonmyung Paik, Sandra M Swain, Dennis C Sgroi, Catherine A Schnabel, Norman Wolmark
Breast Cancer Index and Prediction of Extended Aromatase Inhibitor Therapy Benefit in Hormone Receptor-positive Breast Cancer from the NRG Oncology/NSABP B-42 Trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Eleftherios P P Mamounas, Hanna Bandos, Priya Rastogi, Yi Zhang, Kai Treuner, Peter C Lucas, Charles E Geyer, Louis Fehrenbacher, Stephen K L Chia, Adam M Brufsky, Janice M Walshe, Gamini S Soori, Shaker R Dakhil, Soonmyung Paik, Sandra M Swain, Dennis C Sgroi, Catherine A Schnabel, Norman Wolmark
Breast Cancer Index and Prediction of Extended Aromatase Inhibitor Therapy Benefit in Hormone Receptor-Positive Breast Cancer from the NRG Oncology/NSABP B-42 Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (9) (2024)
Priya Rastogi, Hanna Bandos, Peter C Lucas, Laura van 't Veer, Jia-Perng J Wei, Charles E Geyer, Louis Fehrenbacher, Stephen K L Chia, Adam M Brufsky, Janice M Walshe, Gamini S Soori, Shaker R Dakhil, Soonmyung Paik, Sandra M Swain, Andrea R Menicucci, M William Audeh, Norman Wolmark, Eleftherios P P Mamounas
Utility of the 70-Gene MammaPrint Assay for Prediction of Benefit From Extended Letrozole Therapy in the NRG Oncology/NSABP B-42 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Charles E Geyer, Joanne L Blum, Greg Yothers, Lina Asmar, Patrick J Flynn, Nicholas J Robert, Judith O Hopkins, Joyce A O'Shaughnessy, Priya Rastogi, Shannon L Puhalla, Christie J Hilton, Chau T Dang, Henry Leonidas Gómez, Svetislava J Vukelja, Alan P Lyss, Devchand Paul, Adam M Brufsky, Linda H Colangelo, Sandra M Swain, Eleftherios P P Mamounas, Norman Wolmark
Long-Term Follow-Up of the Anthracyclines in Early Breast Cancer Trials (USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 [NRG Oncology]). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (12) (2024)
Charles E Geyer, Joanne L Blum, Greg Yothers, Lina Asmar, Patrick J Flynn, Nicholas J Robert, Judith O Hopkins, Joyce A O'Shaughnessy, Priya Rastogi, Shannon L Puhalla, Christie J Hilton, Chau T Dang, Henry Leonidas Gómez, Svetislava J Vukelja, Alan P Lyss, Devchand Paul, Adam M Brufsky, Linda H Colangelo, Sandra M Swain, Eleftherios P P Mamounas, Norman Wolmark
Long-Term Follow-Up of the Anthracyclines in Early Breast Cancer Trials (USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 [NRG Oncology]). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (12) (2024)
Priya Rastogi, Hanna Bandos, Peter C Lucas, Laura van 't Veer, Jia-Perng J Wei, Charles E Geyer, Louis Fehrenbacher, Stephen K L Chia, Adam M Brufsky, Janice M Walshe, Gamini S Soori, Shaker R Dakhil, Soonmyung Paik, Sandra M Swain, Andrea R Menicucci, M William Audeh, Norman Wolmark, Eleftherios P P Mamounas
Utility of the 70-Gene MammaPrint Assay for Prediction of Benefit From Extended Letrozole Therapy in the NRG Oncology/NSABP B-42 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Eleftherios P P Mamounas, Hanna Bandos, Priya Rastogi, Yi Zhang, Kai Treuner, Peter C Lucas, Charles E Geyer, Louis Fehrenbacher, Stephen K L Chia, Adam M Brufsky, Janice M Walshe, Gamini S Soori, Shaker R Dakhil, Soonmyung Paik, Sandra M Swain, Dennis C Sgroi, Catherine A Schnabel, Norman Wolmark
Breast Cancer Index and Prediction of Extended Aromatase Inhibitor Therapy Benefit in Hormone Receptor-Positive Breast Cancer from the NRG Oncology/NSABP B-42 Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (9) (2024)
Eleftherios P P Mamounas, Hanna Bandos, Priya Rastogi, Yi Zhang, Kai Treuner, Peter C Lucas, Charles E Geyer, Louis Fehrenbacher, Stephen K L Chia, Adam M Brufsky, Janice M Walshe, Gamini S Soori, Shaker R Dakhil, Soonmyung Paik, Sandra M Swain, Dennis C Sgroi, Catherine A Schnabel, Norman Wolmark
Breast Cancer Index and Prediction of Extended Aromatase Inhibitor Therapy Benefit in Hormone Receptor-positive Breast Cancer from the NRG Oncology/NSABP B-42 Trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Charles E Geyer, Joanne L Blum, Greg Yothers, Lina Asmar, Patrick J Flynn, Nicholas J Robert, Judith O Hopkins, Joyce A O'Shaughnessy, Priya Rastogi, Shannon L Puhalla, Christie J Hilton, Chau T Dang, Henry Leonidas Gómez, Svetislava J Vukelja, Alan P Lyss, Devchand Paul, Adam M Brufsky, Linda H Colangelo, Sandra M Swain, Eleftherios P P Mamounas, Norman Wolmark
Long-Term Follow-Up of the Anthracyclines in Early Breast Cancer Trials (USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 [NRG Oncology]). Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Eleftherios P P Mamounas, Hanna Bandos, Priya Rastogi, Yi Zhang, Kai Treuner, Peter C Lucas, Charles E Geyer, Louis Fehrenbacher, Stephen K L Chia, Adam M Brufsky, Janice M Walshe, Gamini S Soori, Shaker R Dakhil, Soonmyung Paik, Sandra M Swain, Dennis C Sgroi, Catherine A Schnabel, Norman Wolmark
Breast Cancer Index and Prediction of Extended Aromatase Inhibitor Therapy Benefit in Hormone Receptor-Positive Breast Cancer from the NRG Oncology/NSABP B-42 Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (9) (2024)
Priya Rastogi, Hanna Bandos, Peter C Lucas, Laura van 't Veer, Jia-Perng J Wei, Charles E Geyer, Louis Fehrenbacher, Stephen K L Chia, Adam M Brufsky, Janice M Walshe, Gamini S Soori, Shaker R Dakhil, Soonmyung Paik, Sandra M Swain, Andrea R Menicucci, M William Audeh, Norman Wolmark, Eleftherios P P Mamounas
Utility of the 70-Gene MammaPrint Assay for Prediction of Benefit From Extended Letrozole Therapy in the NRG Oncology/NSABP B-42 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Eleftherios P P Mamounas, Hanna Bandos, Priya Rastogi, Yi Zhang, Kai Treuner, Peter C Lucas, Charles E Geyer, Louis Fehrenbacher, Stephen K L Chia, Adam M Brufsky, Janice M Walshe, Gamini S Soori, Shaker R Dakhil, Soonmyung Paik, Sandra M Swain, Dennis C Sgroi, Catherine A Schnabel, Norman Wolmark
Breast Cancer Index and Prediction of Extended Aromatase Inhibitor Therapy Benefit in Hormone Receptor-Positive Breast Cancer from the NRG Oncology/NSABP B-42 Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (9) (2024)
Charles E Geyer, Joanne L Blum, Greg Yothers, Lina Asmar, Patrick J Flynn, Nicholas J Robert, Judith O Hopkins, Joyce A O'Shaughnessy, Priya Rastogi, Shannon L Puhalla, Christie J Hilton, Chau T Dang, Henry Leonidas Gómez, Svetislava J Vukelja, Alan P Lyss, Devchand Paul, Adam M Brufsky, Linda H Colangelo, Sandra M Swain, Eleftherios P P Mamounas, Norman Wolmark
Long-Term Follow-Up of the Anthracyclines in Early Breast Cancer Trials (USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 [NRG Oncology]). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (12) (2024)
Filipa C Lynce, Candace Mainor, Renee N Donahue, Xue Geng, Greg Jones, Ilana Schlam, Hongkun Wang, Nicole J Toney, Caroline Jochems, Jeffrey Schlom, Jay Zeck, Christopher M Gallagher, Rita Nanda, Deena Graham, Erica M Stringer-Reasor, Neelima Denduluri, Julie M Collins, Ami Chitalia, Shruti Tiwari, Raquel A Nunes, Rebecca Kaltman, Katia Khoury, Margaret Gatti-Mays, Paolo Tarantino, Sara M Tolaney, Sandra M Swain, Paula Pohlmann, Heather A Parsons, Claudine Isaacs
Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study. Nature communications 15 (1) (2024)
Filipa C Lynce, Candace Mainor, Renee N Donahue, Xue Geng, Greg Jones, Ilana Schlam, Hongkun Wang, Nicole J Toney, Caroline Jochems, Jeffrey Schlom, Jay Zeck, Christopher M Gallagher, Rita Nanda, Deena Graham, Erica M Stringer-Reasor, Neelima Denduluri, Julie M Collins, Ami Chitalia, Shruti Tiwari, Raquel A Nunes, Rebecca Kaltman, Katia Khoury, Margaret Gatti-Mays, Paolo Tarantino, Sara M Tolaney, Sandra M Swain, Paula Pohlmann, Heather A Parsons, Claudine Isaacs
Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study. Nature communications 15 (1) (2024)
Filipa C Lynce, Candace Mainor, Renee N Donahue, Xue Geng, Greg Jones, Ilana Schlam, Hongkun Wang, Nicole J Toney, Caroline Jochems, Jeffrey Schlom, Jay Zeck, Christopher M Gallagher, Rita Nanda, Deena Graham, Erica M Stringer-Reasor, Neelima Denduluri, Julie M Collins, Ami Chitalia, Shruti Tiwari, Raquel A Nunes, Rebecca Kaltman, Katia Khoury, Margaret Gatti-Mays, Paolo Tarantino, Sara M Tolaney, Sandra M Swain, Paula Pohlmann, Heather A Parsons, Claudine Isaacs
Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study. Nature communications 15 (1) (2024)
Filipa C Lynce, Candace Mainor, Renee N Donahue, Xue Geng, Greg Jones, Ilana Schlam, Hongkun Wang, Nicole J Toney, Caroline Jochems, Jeffrey Schlom, Jay Zeck, Christopher M Gallagher, Rita Nanda, Deena Graham, Erica M Stringer-Reasor, Neelima Denduluri, Julie M Collins, Ami Chitalia, Shruti Tiwari, Raquel A Nunes, Rebecca Kaltman, Katia Khoury, Margaret Gatti-Mays, Paolo Tarantino, Sara M Tolaney, Sandra M Swain, Paula Pohlmann, Heather A Parsons, Claudine Isaacs
Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study. Nature communications 15 (1) (2024)
Manjeet Chadha, J White, Sandra M Swain, E Rakovitch, R Jagsi, Timothy J Whelan, Joseph A Sparano
Optimal adjuvant therapy in older (≥70 years of age) women with low-risk early-stage breast cancer. NPJ breast cancer 9 (1) (2023)
Nadia Ashai, Sandra M Swain
Post-CDK 4/6 Inhibitor Therapy: Current Agents and Novel Targets. Cancers 15 (6) (2023)
Sharyn D Baker, Susan E Bates, Gabriel A Brooks, William L Dahut, Robert B Diasio, Wafik S El-Deiry, William E Evans, William Douglas Figg, Daniel Louis Hertz, J Kevin Hicks, Suneel D Kamath, Pashtoon Murtaza Kasi, Todd C Knepper, Howard L McLeod, Peter H O'Donnell, Mary V Relling, Michelle A Rudek, Tristan M Sissung, D Max Smith, Alex Sparreboom, Sandra M Swain, Christine M Walko
DPYD Testing: Time to Put Patient Safety First. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Nadia Ashai, Sandra M Swain
Post-CDK 4/6 Inhibitor Therapy: Current Agents and Novel Targets. Cancers 15 (6) (2023)
Letizia Polito, Jinjoo Shim, Sara Alsterlind Hurvitz, Chau T Dang, Adam Knott, Yolande du Toit, Eleonora Restuccia, Thibaut Sanglier, Sandra M Swain
Real-World First-Line Use of Pertuzumab With Different Taxanes for Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: A Comparative Effectiveness Study Using US Electronic Health Records. JCO oncology practice (2023)
Manjeet Chadha, J White, Sandra M Swain, E Rakovitch, R Jagsi, Timothy J Whelan, Joseph A Sparano
Optimal adjuvant therapy in older (≥70 years of age) women with low-risk early-stage breast cancer. NPJ breast cancer 9 (1) (2023)
Meghna Bhatt, Beth N Peshkin, Sadaf Kazi, Marc D Schwartz, Nadia Ashai, Sandra M Swain, D Max Smith
Pharmacogenomic testing in oncology: a health system's approach to identify oncology provider perspectives. Pharmacogenomics (2023)
Manjeet Chadha, J White, Sandra M Swain, E Rakovitch, R Jagsi, Timothy J Whelan, Joseph A Sparano
Optimal adjuvant therapy in older (≥70 years of age) women with low-risk early-stage breast cancer. NPJ breast cancer 9 (1) (2023)
Sandra M Swain, Mythili Shastry, Erika Paige Hamilton
Targeting HER2-positive breast cancer: advances and future directions. Nature reviews. Drug discovery (2022)
Paula R Pohlmann, Deena Graham, Tianmin Wu, Yvonne Ottaviano, Mahsa Mohebtash, Shweta Kurian, Donna McNamara, Filipa C Lynce, Robert Warren, Asma Dilawari, Suman Rao, Candace Mainor, Nicole Swanson, Ming T Tan, Claudine Isaacs, Sandra M Swain
HALT-D: a randomized open-label phase II study of crofelemer for the prevention of chemotherapy-induced diarrhea in patients with HER2-positive breast cancer receiving trastuzumab, pertuzumab, and a taxane. Breast cancer research and treatment 196 (3) (2022)
Sandra M Swain, Harrison Macharia, Javier Cortes, Chau T Dang, Luca Gianni, Sara A Hurvitz, Christian Jackisch, Andreas Schneeweiss, Dennis Slamon, Pinuccia Valagussa, Yolande du Toit, Dominik Heinzmann, Adam Knott, Chunyan Song, Patricia Cortazar
Event-Free Survival in Patients with Early HER2-Positive Breast Cancer with a Pathological Complete Response after HER2-Targeted Therapy: A Pooled Analysis. Cancers 14 (20) (2022)
Andrew J Lee, Adrian C Hui, Alexander D Walker, Beth N Peshkin, Sandra M Swain, D Max Smith
Evaluation of a longitudinal pharmacogenomics education on pharmacist knowledge in a multicampus healthcare system. Pharmacogenomics 23 (3) (2022)
Michael S Ewer, Sandra M Swain
Could Some Reports of Trastuzumab Cardiotoxicity Be a Surveillance Artifact? Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (35) (2022)
Ilana Schlam, Sandra M Swain
HER2-positive breast cancer and tyrosine kinase inhibitors: the time is now. NPJ breast cancer 7 (1) (2021)
Ilana Schlam, Sarah E Church, Tyler D Hether, Krysta Chaldekas, Briana M Hudson, Andrew M White, Emily Maisonet, Brent T Harris, Sandra M Swain
The tumor immune microenvironment of primary and metastatic HER2- positive breast cancers utilizing gene expression and spatial proteomic profiling. Journal of translational medicine 19 (1) (2021)
Sony Tuteja, Ramzi George Salloum, Amanda L Elchynski, D Max Smith, Elizabeth J Rowe, Kathryn V Blake, Nita A Limdi, Christina L Aquilante, Jill Bates, Amber L Beitelshees, Amber B Cipriani, Benjamin Q Duong, Philip E Empey, Christine M Formea, J Kevin Hicks, Pawel Mroz, David Oslin, Amy L Pasternak, Natasha J Petry, Laura B Ramsey, Allyson Schlichte, Sandra M Swain, Kristen M Ward, Kristin Wiisanen, Todd C Skaar, Sara L Van Driest, Larisa H Cavallari, Jeffrey R Bishop, null null
Multisite evaluation of institutional processes and implementation determinants for pharmacogenetic testing to guide antidepressant therapy. Clinical and translational science (2021)
Ian E Krop, Seock-Ah Im, Carlos Henrique Barrios, Hervé R Bonnefoi, Julie R Gralow, Masakazu Toi, Paul A Ellis, Luca Gianni, Sandra M Swain, Young-Hyuck Im, Michelino De Laurentiis, Zbigniew Nowecki, Chiun-Sheng Huang, Louis Fehrenbacher, Yoshinori Ito, Jigna Shah, Thomas Boulet, Haiying Liu, Harrison Macharia, Peter Trask, Chunyan Song, Eric P Winer, Nadia Harbeck
Trastuzumab Emtansine Plus Pertuzumab Versus Taxane Plus Trastuzumab Plus Pertuzumab After Anthracycline for High-Risk Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer: The Phase III KAITLIN Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)
Katia Khoury, Filipa Lynce, Ana Barac, Xue Geng, Chau Dang, Anthony F Yu, Karen L Smith, Christopher Gallagher, Paula R Pohlmann, Raquel Nunes, Pia Herbolsheimer, Robert Warren, Monvadi B Srichai, Mark Hofmeyer, Federico Asch, Ming Tan, Claudine Isaacs, Sandra M Swain
Long-term follow-up assessment of cardiac safety in SAFE-HEaRt, a clinical trial evaluating the use of HER2-targeted therapies in patients with breast cancer and compromised heart function. Breast cancer research and treatment 185 (3) (2021)
Sandra M Swain, Gong Tang, Heather Ann Brauer, David S Goerlitz, Peter C Lucas, André Robidoux, Brent T Harris, Hanna Bandos, Yuqi Ren, Charles E Geyer, Priya Rastogi, Eleftherios P Mamounas, Norman Wolmark
NSABP B-41, a Randomized Neoadjuvant Trial: Genes and Signatures Associated with Pathologic Complete Response. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (16) (2020)
Sandra M Swain, Gong Tang, Peter C Lucas, André Robidoux, David Goerlitz, Brent T Harris, Hanna Bandos, Charles E Geyer, Priya Rastogi, Eleftherios P Mamounas, Norman Wolmark
Pathologic complete response and outcomes by intrinsic subtypes in NSABP B-41, a randomized neoadjuvant trial of chemotherapy with trastuzumab, lapatinib, or the combination. Breast cancer research and treatment 178 (2) (2019)
F Lynce, A Barac, X Geng, C Dang, A F Yu, K L Smith, C Gallagher, P R Pohlmann, R Nunes, P Herbolsheimer, R Warren, M B Srichai, M Hofmeyer, A Cunningham, P Timothee, F M Asch, A Shajahan-Haq, M T Tan, C Isaacs, Sandra M Swain
Prospective evaluation of the cardiac safety of HER2-targeted therapies in patients with HER2-positive breast cancer and compromised heart function: the SAFE-HEaRt study. Breast cancer research and treatment 175 (3) (2019)
Melody Cobleigh, Denise A Yardley, Adam M Brufsky, Hope S Rugo, Sandra M Swain, Peter A Kaufman, Debu Tripathy, Sara A Hurvitz, Joyce O'Shaughnessy, Ginny Mason, Vincent Antao, Haocheng Li, Laura Chu, Mohammad Jahanzeb
Baseline Characteristics, Treatment Patterns, and Outcomes in Patients with HER2-Positive Metastatic Breast Cancer by Hormone Receptor Status from SystHERs. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (5) (2019)
Sara A Hurvitz, Joyce O'Shaughnessy, Ginny Mason, Denise A Yardley, Mohammad Jahanzeb, Adam Brufsky, Hope S Rugo, Sandra M Swain, Peter A Kaufman, Debu Tripathy, Laura Chu, Haocheng Li, Vincent Antao, Melody Cobleigh
Central Nervous System Metastasis in Patients with HER2-Positive Metastatic Breast Cancer: Patient Characteristics, Treatment, and Survival from SystHERs. Clinical cancer research : an official journal of the American Association for Cancer Research 25 (8) (2018)
Jennifer J Gao, Sandra M Swain
Luminal A Breast Cancer and Molecular Assays: A Review. The oncologist 23 (5) (2018)
Brandi N Robinson, Antoinette F Newman, Eshetu Tefera, Pia Herbolsheimer, Raquel Nunes, Christopher Gallagher, Pamela Randolph-Jackson, Adedamola Omogbehin, Asma Dilawari, Paula R Pohlmann, Mahsa Mohebtash, Young Lee, Yvonne Ottaviano, Avani Mohapatra, Filipa Lynce, Richard Brown, Mihriye Mete, Sandra M Swain
Video intervention increases participation of black breast cancer patients in therapeutic trials. NPJ breast cancer 3 (2017)
Elmer E Huerta, Patricia Weeks-Coulthurst, Courtney Williams, Sandra M Swain
Take care of your neighborhood. Breast cancer research and treatment 167 (1) (2017)